Eucrisa (crisaborole) / Pfizer 
Welcome,         Profile    Billing    Logout  

13 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Eucrisa (crisaborole) / Pfizer
NCT04214197: Study of Crisaborole Ointment 2% in Mild to Moderate Atopic Dermatitis

Active, not recruiting
4
150
US
Crisaborole 2% Top Oint
Massachusetts General Hospital, Pfizer
Atopic Dermatitis
07/21
08/21
ChiCTR2100051499: Clinical observation of Crisaborole Ointment in the treatment of scrotal eczema

Recruiting
4
176
 
topical crisaborole ointment for 2 weeks ;topical vaseline for 2 weeks
Dermatology Hospital of Southern Medical University; Dematology Hospital of Southern Medical University, Pfizer Pharmaceuticals Ltd.
scrotal eczema
 
 
ChiCTR2300068426: Early relief of clinical symptoms and the improvement during the maintenance period of childhood atopic dermatitis: A multicenter clinical study of crisaborole ointment

Recruiting
4
150
 
Crisaborole Bid, then Qod in Maintenance Period ;Crisaborole Bid, then Biw in Maintenance Period
Beijng Children's Hospital, Capital Medical University; Beijng Children's Hospital, Capital Medical University, China National Health Association
Atopic dermatits
 
 
ChiCTR2200060584: A randomized controlled study comparing the efficacy and safety of 2% Crisaborole ointment versus 1% Pimemollimus cream in the treatment of mild to moderate atopic dermatitis in children aged 2 years and older

Recruiting
4
120
 
Topical use of Crisaborole, twice a day ;Topical use of Pimecrolimus, twice a day
Shenzhen Children's Hospital; Shenzhen Children's Hospital, Chinese National Health Association
Atopic dermatitis
 
 
NCT03832010: Steroid-reducing Effects of Crisaborole

Completed
4
24
US
Crisaborole, Eucrisa, Hydrocortisone Ointment, Triamcinolone ointment, Aquaphor
Johns Hopkins University, Pfizer
Atopic Dermatitis, Eczema
02/24
02/24
PAD, NCT05200403: Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitis

Terminated
4
118
US
Crisaborole 2%, EUCRISA, Vehicle treatment, Nonmedicated ointment, Accelerometry device for children, Accelerometry device for adult caregivers
Boston University
Atopic Dermatitis
02/24
02/24
2019-002643-23: Skin bioMARkers for atopic eczema Therapy evaluation

Not yet recruiting
2
37
Europe
Eucrisa, Betnovate Cream, Crisaborole PF-06930164, 10949/0014, Ointment, Cream, Eucrisa, Betnovate Cream
Sheffield Teaching Hospitals NHS Foundation Trust, Pfizer Inc.
atopic eczema (synonym atopic dermatitis) and the adverse treatment side effect epidermal atrophy, atopic eczema (synonym atopic dermatitis) is a chronic, relapsing, inflammatory disease of the skin. Epidermal atrophy is skin thinning, Diseases [C] - Skin and Connective Tissue Diseases [C17]
 
 
NCT05298033: Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo

Completed
2
32
US
Crisaborole 2 % Topical Ointment, Eucrisa, PF-07038124 0.01% topical ointment, NBUVB phototherapy, Narrow band UVB, Sham phototherapy, Vehicle
University of Colorado, Denver, Pfizer
Vitiligo
04/24
04/24
COSTIC, NCT06118047: Crisaborole Ointment for Skin Toxicity Induced by Cetuximab

Recruiting
2
33
RoW
Crisaborole Ointment, Cetuximab
Sun Yat-sen University
Metastatic Colorectal Cancer, Cetuximab, Skin Toxicity
12/24
12/25
NCT04800185: Characterizing Skin Microbiome Change in Atopic Dermatitis

Completed
1
20
US
Crisaborole 2% Top Oint, Skin Microbiome Swabs
University of California, Irvine, Pfizer
Atopic Dermatitis, Atopic Dermatitis Eczema
04/22
04/22
NCT03250663: Eucrisa for Atopic Dermatitis

Active, not recruiting
1
28
US
Online Treatment response, EUCRISA
Wake Forest University Health Sciences
Mild to Moderate Atopic Dermatitis
01/25
07/25
NCT03770858: Wearable Skin Sensors to Assess Nocturnal Scratch Behavior

Completed
N/A
23
US
Crisaborole, Scratch sensor
Northwestern University, Pfizer
Atopic Dermatitis
08/21
08/22
ChiCTR2100054340: Multi-center clinical efficacy and safety observation of sequential topical application of 0.1% mometasone furoate cream and 2% criborole ointment in the treatment of mild to moderate atopic dermatitis in children 2 years old and older

Not yet recruiting
N/A
156
 
Sequential topical application of mometasone furoate cream and crisaborole ointment ;Sequential topical application of mometasone furoate cream and emollients
Children's Hospital of Chongqing Medical University; Children's Hospital of Chongqing Medical University, China National Health Association
Atopic dermatitis
 
 

Download Options